XLON
BOY
Market cap1.47bUSD
Jul 10, Last price
648.00GBP
1D
0.54%
1Q
-6.22%
Jan 2017
0.62%
Name
Bodycote PLC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Bodycote plc, established in 1923 and based in Macclesfield, United Kingdom, offers specialized heat treatment and thermal processing solutions globally. The company operates within two key divisions: Aerospace, Defence & Energy, and Automotive & General Industrial, serving diverse sectors including automotive, aerospace and defense, energy, and broader industrial markets. A primary service involves heat treatment, which strategically alters the microstructure of metals and alloys like steel and aluminum to impart crucial properties such as increased surface hardness, enhanced temperature resistance, improved ductility, and greater strength. Bodycote also excels in various metal joining techniques, encompassing electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and both vacuum and honeycomb brazing. Their advanced capabilities extend to hot isostatic pressing (HIP) services, which include standard isostatic pressing and related support, as well as their proprietary Powdermet technology for manufacturing intricate components through powder metallurgy. Furthermore, Bodycote provides a comprehensive suite of surface technologies engineered to prolong component lifespan and shield them from environmental factors like corrosion and abrasion. These sophisticated surface treatments range from anodizing and ceramic coatings to various thermal spraying methods (flame, combustion, high velocity oxygen fuel, plasma, electric arc), aluminide coatings, liquid coatings, and thermo-chemically formed ceramic coatings, all designed to boost wear resistance and corrosion protection.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||